A pain-informed model identified risk factors for clinically significant nausea in patients undergoing metabolic bariatric surgery.

A key gene tied to hyperemesis gravidarum, an extreme form of vomiting in pregnancy, is also linked to a heightened risk of ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major ...

New findings could partially help explain why some people appear to lose weight more quickly than others while taking the ...

A study involving nearly 28,000 people identifies the genes that may influence weight loss with Ozempic and Mounjaro.

There are many reasons a cat might vomit, and not all of them are serious. But depending on the circumstances and frequency, it could be a serious reason for concern. Cats have a special talent for ...

An employee working in the kitchen while ill and vomiting, an employee who touched food after tucking in their shirt, dead mice, mouse poop, bugs in milk, food that wasn’t properly labeled, gnats on ...

Researchers have developed a novel GLP-1 receptor agonist that preserves blood sugar control while reducing nausea and vomiting, offering a potential safer approach to treating diabetes and obesity.

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, obesity, or other conditions, according to a KFF Health Tracking poll. But many ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

The FDA has released draft guidance outlining an approval pathway for individualized therapies aimed at ultra-rare diseases, building on a framework first outlined by agency leaders in November. The ...